CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-14 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −5,710 | 5,712 | ||
| 2020-02-14 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −19,040 | 0 | ||
| 2020-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +5,353 | 38,682.51 | ||
| 2020-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +17,850 | 56,532.51 | ||
| 2020-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −2,647 | $12.14 | $32K | 53,885.51 |
| 2020-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −8,825 | $12.14 | $107K | 45,060.51 |
| 2020-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −5,353 | 5,355 | ||
| 2020-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −17,850 | 0 | ||
| 2020-02-14 | Drape Eric Executive VP Global Operations | Option exercise | +13,090 | 33,708 | ||
| 2020-02-14 | Drape Eric Executive VP Global Operations | Option exercise | +3,926 | 37,634 | ||
| 2020-02-14 | Drape Eric Executive VP Global Operations | Sale | −6,262 | $12.14 | $76K | 31,372 |
| 2020-02-14 | Drape Eric Executive VP Global Operations | Sale | −1,878 | $12.14 | $23K | 29,494 |
| 2020-02-14 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −13,090 | 0 | ||
| 2020-02-14 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −3,926 | 3,926 | ||
| 2020-02-14 | BARER SOL J Director | Option exercise | +2,470 | 222,912 | ||
| 2020-02-14 | BARER SOL J Director | Option exercise · Restricted Share Units | −2,470 | 0 | ||
| 2020-02-13 | Sabag Mark See "Remarks" below | Sale | −72,130.54 | $13.03 | $940K | 0 |
| 2020-02-13 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Grant or award · Restricted Share Units | +19,888 | 19,888 | ||
| 2020-02-11 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award · Restricted Share Units | +13,090 | 13,090 | ||
| 2020-02-11 | Schultz Kare President and CEO | Grant or award · Restricted Share Units | +212,314 | 212,314 |
Page 59 of 76 · 1,517 trades